CTRI/2021/06/034004尚未招募未知
PILOT STUDY TO ASSESS THE EFFECTIVENESS OF INTRALIPID EMULSION IN REDUCING MORTALITY IN ALUMINUM PHOSPHIDE POISONING - ILINALP
Intra Mural sponsoring body of PGIMER0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •All the cases with the primary diagnosis of Aluminum phosphide toxicity will be included in the study.
- •Willing and able to comply with the study procedures and provide written informed consent to participate in the study.
排除标准
- •Patients with a history of any chronic disease (renal and hepatic,cardiac)
- •Patients refuse to participate in the study.
- •Aged less than 18 years
研究者
相似试验
进行中（未招募）
1 期
PILOT STUDY TO ASSESS THE EFFICACY AND SAFETY OF SWITCHING PROTEASE INHIBITOR TO ETRAVIRINE IN HIV-1-INFECTED SUBJECTS WITH VIREMIA SUPPRESSION (ESTUDIO PILOTO PARA EVALUAR LA EFICACIA Y SEGURIDAD DE LA SIMPLIFICACIÓN DE UN INHIBIDOR DE LA PROTEASA A ETRAVIRINA EN PACIENTES CON INFECCIÓN POR EL VIH-1 EN SUPRESIÓN VIRAL)Infección por el VIH.MedDRA version: 9Level: LLTClassification code 10008919Term: Chronic HIV infectionEUCTR2009-016455-21-ESFundació Lluita contra la SIDA
进行中（未招募）
不适用
PILOT STUDY FOR THE EVALUATION OF THE EFFECTS OF INSULIN TREATMENT ON MYOCARDIAL FUNCTION, PERFUSION, AND GLUCOSE METABOLISM IN PATIENTS WITH PRIMARY LEFT VENTRICULAR DYSFUNCTION AND TYPE 2 DIABETESEUCTR2004-002729-34-ITAVENTIS PHARMA S.P.A.
尚未招募
1 期
A pilot study to evaluate the effectiveness of intranasal Botulinum Toxin Type A Spray for patients with RhinitisInflammatory and Immune System - AllergiesInflammatory and Immune System - Other inflammatory or immune system disordersAllergic RhinitisNon-Allergic RhinitisACTRN12624000772549Metro North Hospital and Health Service15
已完成
2 期
AYUSH 64 for accelerating the recovery in cases of InfluenzaCTRI/2017/10/010145Central Council for Research in Ayurvedic Sciences Ministry of AYUSH GoI
进行中（未招募）
1 期
A PILOT STUDY TO EVALUATE THE EFFECT OF TRIGGERING FINAL OOCYTE MATURATION WITH GnRHa OR hCG ON ENDOMETRIAL RECEPTIVITY PARAMETERS AND THE LUTEAL PHASE IN OOCYTE DONORS - GnRHa vs hCG: impact on endometrial receptivityCompare the endometrium of oocyte donors, who had final oocyte maturation with either hCG, Suprefact, followed by hCG 35 hours after triggering, Suprefact or Suprefact without luteal phase support.Group A, B, C receive luteal phase support for 5 days, until the day of endometrial sampling (OPU+5).To avoid inter-patient variation in endometrial histology, each patient will preferably perform 4 consecutive oocyte donation cycles, within one year, using models A-D for final oocyte maturationEUCTR2009-009429-26-BEFREE UNIVERSITY OF BRUSSELS